| [1] |
Matsuda T, Fujimoto A, Igarashi Y. Colorectal Cancer: Epidemiology, Risk Factors, and Public Health Strategies[J]. Digestion, 2025, 106(2): 91-99.
|
| [2] |
Leowattana W, Leowattana P, Leowattana T. Systemic treatment for metastatic colorectal cancer[J]. World J Gastroenterol, 2023, 29(10): 1569-1588.
|
| [3] |
Wu Y, Xiao Y, Ding Y, et al. Colorectal cancer cell-derived exosomal miRNA-372-5p induces immune escape from colorectal cancer via PTEN/AKT/NF-κB/PD-L1 pathway[J]. Int Immunopharmacol, 2024, 143(Pt 1): 113261.
|
| [4] |
Zhuang J, Shen L, Li M, et al. Cancer-Associated Fibroblast-Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistance[J]. Cancer Res, 2023, 83(10): 1611-1627.
|
| [5] |
陈辉国, 周亚夫, 颜建华, 等. 肺癌miR-146a表达及其对细胞增殖,侵袭及迁移的影响[J]. 临床肿瘤学杂志, 2020, 219(3): 37-42.
|
| [6] |
Sun X, Cui S, Fu X, et al. MicroRNA-146-5p promotes proliferation, migration and invasion in lung cancer cells by targeting claudin-12 [J]. Cancer Biomark, 2019, 25(1): 89-99.
|
| [7] |
Gui H, Nie Y, Yuan H, et al. The combination of a PTP1B inhibitor, TNFR2 blocker, and PD1 antibody suppresses the progression of nonsmall cell lung cancer tumors by enhancing immunocompetence [J]. Oncol Rep, 2024, 52(5): 149.
|
| [8] |
余红璐, 任亚君, 熊枝繁. PTPlB和Sam68在结直肠癌中的表达及其意义[J]. 山西医科大学学报, 2017, 48(6): 596-601.
|
| [9] |
Yang Q, Zhang L, Zhong Y, et al. miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma[J]. Biosci Rep, 2019, 39(5): 1-14.
|
| [10] |
Abedizadeh R, Majidi F, Khorasani HR, et al. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments[J]. Cancer Metastasis Rev, 2024, 43(2): 729-753.
|
| [11] |
Moorman A, Benitez EK, Cambulli F, et al. Progressive plasticity during colorectal cancer metastasis[J]. Nature, 2025, 637(8047): 947-954.
|
| [12] |
Panoutsopoulou K, Liu Y, Avgeris M, et al. Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancer[J]. Clin Biochem, 2023, 114: 43-51.
|
| [13] |
邢智伟, 高紫玉, 高雅楠, 等. LncRNA MALAT1通过靶向miR-146a调节PI3K/Akt信号通路影响胃癌细胞的增殖、迁移和侵袭[J]. 沈阳药科大学学报, 2024, 41(5): 581-589, 618.
|
| [14] |
Noorolyai S, Baghbani E, Aghebati Maleki L, et al. Restoration of miR-193a-5p and miR-146 a-5p Expression Induces G1 Arrest in Colorectal Cancer through Targeting of MDM2/p53[J]. Adv Pharm Bull, 2020, 10(1): 130-134.
|
| [15] |
Chen J, Jiang Q, Jiang XQ, et al. miR-146a promoted breast cancer proliferation and invasion by regulating NM23-H1[J]. J Biochem, 2020, 167(1): 41-48.
|
| [16] |
梁雪, 吕磊, 钱立庭, 等. miR-146a-5p靶向IRAK1, TRAF6抑制小细胞肺癌耐药[J]. 安徽医科大学学报, 2020, 55(3): 333-339.
|
| [17] |
Liang S, Tran E, Du X, et al. A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity[J]. Nat Commun, 2023, 14(1): 4524.
|
| [18] |
Huang WC, Yen JH, Sung YW, et al. Novel function of THEMIS2 in the enhancement of cancer stemness and chemoresistance by releasing PTP1B from MET[J]. Oncogene, 2022, 41(7): 997-1010.
|
| [19] |
Li Y, Luo H, Lin X, et al. Triterpenes of Prunella vulgaris Inhibit Triple-Negative Breast Cancer by Regulating PTP1B/PI3K/AKT/ mTOR and IL-24/CXCL12/CXCR4 Pathways[J]. Int J Mol Sci, 2025, 26(5): 1959.
|
| [20] |
Zhu S, Bjorge JD, Fujita DJ. PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation[J]. Cancer Res, 2007, 67(21): 10129-10137.
|
| [21] |
Hoekstra E, Das AM, Swets M, et al. Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome[J]. Oncotarget, 2016, 7(16): 21922-21938.
|